Covid-19 Diagnostic Resources for Low- and Middle-Income Countries/

Dashboards | Covid-19 Diagnostics

Data available on Covid-19 testing resources have been evolving rapidly since the onset of the pandemic. This set of interactive dashboards provides users with a mechanism to sort and filter three separate databases using key product features (including diagnostic target, platform type, sensitivity, specificity, time to results, throughput, etc.). While they function in a similar manner, the selection and sort criteria vary depending upon which of the three databases is being viewed: tests, swabs, or equipment.

The dashboards have similar interactive functionality. At the bottom of the page is a table that displays the database records, at the top are graphs that enable the user to set filters based upon different categories of data. Because the database of tests has the most detailed metadata, the last field is a hyperlink that will let you display a complete record in form, rather than tabular view. Other hyperlinks in the table will lead the user to detailed specifications of the tests, swabs or equipment on the manufacturer’s site.

The data contained in the Dashboards on this site have been compiled from public data sources, key informant interviews, as well as Arizona State University’s Testing Commons.

Testing, Swab, and Equipment Dashboards

  • Testing Dashboard

    This is an interactive dashboard displaying information about Covid-19 tests.

  • Swab Dashboard

    This is an interactive dashboard displaying data about Covid-19 testing swabs.

  • Equipment Dashboard

    This is an interactive dashboard displaying data about Covid-19 testing equipment.

 

DISCLAIMER:

Due the dynamic nature of diagnostics market, this documentation and information will be updated periodically.

MSH and The Rockefeller Foundation do not guarantee the accuracy, completeness or integrity of the information collected from the secondary data sources and interviewees.  Further, the information is provided for informational purposes only and is not intended as an endorsement, guidance, recommendations, or advice for any particular product, program or policy. Any use or interpretation of or reliance on the information for any purpose, is solely and exclusively the responsibility of the recipients of the information. THE INFORMATION IS PROVIDED “AS IS”. NO WARRANTY OF ANY KIND IS GIVEN FOR THE INFORMATION UNDER ANY NATIONAL OR INTERNATIONAL LAW, INCLUDING WARRANTY AGAINST INFRINGEMENT OF INTELLECTUAL PROPERTY. MSH AND THE ROCKEFELLER FOUNDATION expressly disclaim and assume no responsibility for any losses, damages, claims, or other liabilities, including loss of good will, revenue, profits, or business interruption, or any consequential, special, indirect, incidental, punitive or exemplary loss, including costs of defense or attorneys’ fees, arising out of or relating to use of this information. It is expressly understood that the MSH and The Rockefeller Foundation, by providing this information, have no obligation to update the information or provide additional support or information to the recipient.

Related Updates

Dec 02 2020
 
Landscape Analysis | Covid-19 Laboratory Technologies
More
Dec 02 2020
 
Covid-19 Diagnostic Resources for Low- and Middle-Income Countries
More
Dec 02 2020
 
Supply Chain Guidance | Covid-19 Diagnostics
More
Back to Top